Immune Profiling World Congress Brochure
 

2017 BROCHURE

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the 18th annual World Vaccine Congress, World Veterinary Vaccine Congress and Immune Profiling World Congress, we have content, networking and potential partners for you. 

Download the brochure to find out exactly what's in store for this year's event.
 
DOWNLOAD NOW

Our Story


With the development of newer and more advanced immune profiling technologies, we are getting to better understand the complexities of the human immune system. This includes infection, vaccination as well as how diseases or pathogens alter immune cell repertoires and their functional activities.

Following the successful Immune Profiling Congress 2016 meeting in Barcelona, the event will again focus on bringing together experts to discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and non-infectious diseases including cancer.

 

SEE 2017 AGENDA

 

COLOCATED WITH

World Vaccine Congress, Logo

World Veterinary Vaccine Congress Logo

 

SPONSOR OR EXHIBIT

2017 Scientific Advisory Board

 

Professor Albert OsterhausProfessor Albert Osterhaus
Director, Research Center for Emerging Infections and Zoonoses (RIZ)
University of Veterinary Medicine Hannover

Dr Jerald SadoffDr Jerald Sadoff
Senior Advisor
Janssen Infectious Diseases and Vaccines

Dr Jeffrey Almond Dr Jeffrey Almond
Former Vice President Discovery Research and Development, Sanofi and Visiting Professor
University of Oxford - Oxford Vaccine Group

 

Dr Jan Poolman Dr Jan Poolman
Head Bacterial Vaccine Discovery and Early Development
Janssen

Dr Antu Dey Dr Antu Dey
Senior Director, Research & Development
International AIDS Vaccine Initiative

 

Dr Rino Rappuoli Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Dr Roy Baynes is Senior Vice President Global Clinical Development and Chief Medical Officer, MSDDr Roy Baynes
Senior Vice President Global Clinical Development and Chief Medical Officer
MSD

Dr Nathalie Garçon, CEO & CSO, BIOASTERDr Nathalie Garçon
CEO & CSO
BIOASTER

 

Dr Cyril Gay, Senior National Program Leader, Office of National Programs, USDADr Cyril Gay
Senior National Program Leader, Office of National Programs
USDA

Konrad Stradler, Head of R&D Vaccines, Boehringer Ingelheim Konrad Stradler
Head of R&D Vaccines
Boehringer Ingelheim 

Dr Mahesh Kumar, Vice President, Global Biologics Research, ZoetisDr Mahesh Kumar
Vice President, Global Biologics Research
Zoetis

Bernard Vallat, Honorary Director General, Office International Des EpizootiesBernard Vallat
Honorary Director General
Office International Des Epizooties

 

Focused on the key trends changing the immune profiling business


Take just twodays out of the office to find solutions to challenges around the commercial and scientific issues in your business. 

CHARACTERISATION OF THE IMMUNERESPONSE

BIOMARKERS AND SURROGATE MARKERS OF VACCINE EFFICACY AND SAFETY

IMMUNOSEQUENCING AND HIGH THROUGHPUT ANALYSIS

IMMUNOTHERAPY AND PROFILING IN CANCER

 

2017 Speakers

 

  • Dr Philip Arlen at Immune Profiling World Congress
    Dr Philip Arlen
    President and Chief Executive Officer
    Precision Biologics Inc
    Dr Roy Baynes at Immune Profiling World Congress
    Dr Roy Baynes
    SVP of Head Global Clinical Development, CMO
    Merck Research Laboratories (MSD)
  • Dr Annaliesa Anderson at Immune Profiling World Congress
    Dr Annaliesa Anderson
    Vice President and CSO Bacterial Vaccines
    Pfizer
    Dr Jo Brewer at Immune Profiling World Congress
    Dr Jo Brewer
    VP Platform Science
    Adaptimmune
  • Dr Norman Begg at Immune Profiling World Congress
    Dr Norman Begg
    Chief Medical Officer
    GSK Vaccines
    Dr Tanja De Gruijl at Immune Profiling World Congress
    Dr Tanja De Gruijl
    Professor of Translational Tumor Immunology
    Vumc Cancer Center
  • Dr Trent Carrier at Immune Profiling World Congress
    Dr Trent Carrier
    Vice President - Vaccine Technology and Engineering
    Takeda
    Dr James Cummings at Immune Profiling World Congress
    Dr James Cummings
    Vice President, Clinical Development and Translational Medicine
    Novavax
  • Dr Ali M. Harandi at Immune Profiling World Congress
    Dr Ali M. Harandi
    Lab head, Dpt of Microbiology & Immunology
    University of Gothenburg
    Dr David Krige at Immune Profiling World Congress
    Dr David Krige
    Head of Biomarkers
    Immunocore Limited
  • Dr Adrian McDermott at Immune Profiling World Congress
    Dr Adrian McDermott
    Acting Chief, Immunology Core, Vaccine Research Center
    NIAID
    Dr Krishna M Ella at Immune Profiling World Congress
    Dr Krishna M Ella
    Founder and Chairman
    Bharat Biotech International Ltd
  • Paul Moore at Immune Profiling World Congress
    Paul Moore
    Vice President, Cell Biology & Immunology
    Macro Genics Inc
    Dr Dafne Mueller at Immune Profiling World Congress
    Dr Dafne Mueller
    Group Leader, Institute of Cell Biology and Immunology
    University of Stuttgart
  • Salim Mujais at Immune Profiling World Congress
    Salim Mujais
    Senior Vice President of Therapeutic Area Head, Immunology. Transplant, Infectious Disease, CNS & Pain
    Astellas Pharma Inc
    Dr Martin Friede at Immune Profiling World Congress
    Dr Martin Friede
    Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department
    WHO
  • Dr Farshad Guirakhoo at Immune Profiling World Congress
    Dr Farshad Guirakhoo
    Senior Vice President, Research & Development
    GeoVax, Inc.
    Dr Laura Rosa Brunet at Immune Profiling World Congress
    Dr Laura Rosa Brunet
    Chief Scientific Officer
    Immodulon Therapeutics Ltd
  • Dr Maja Sommerfelt at Immune Profiling World Congress
    Dr Maja Sommerfelt
    Chief Scientific Officer
    Bionor Immuno AS
    Dr Suresh Jadhav at Immune Profiling World Congress
    Dr Suresh Jadhav
    Executive Director
    Serum Institute of India
  • Dr Jun Wang at Immune Profiling World Congress
    Dr Jun Wang
    Cancer Immunotherapy, Product Development Oncology, Cancer Immunotherapy Franchise
    Genentech
    Patricia Londono-Hayes at Immune Profiling World Congress
    Patricia Londono-Hayes
    Sr. Director / Head R&D Initiatives, Europe
    Sanofi
  • Dr Anna-Karin Maltais at Immune Profiling World Congress
    Dr Anna-Karin Maltais
    Chief Scientific Officer
    Eurocine Vaccines AB
    Dr Marie Paule Kieny at Immune Profiling World Congress
    Dr Marie Paule Kieny
    Assistant Director General
    World Health Organization
  • Dr K Vijay Raghavan at Immune Profiling World Congress
    Dr K Vijay Raghavan
    Secretary, Department of Biotechnology Ministry of Science and Technology
    Government of India
    Hui (David) Shao at Immune Profiling World Congress
    Hui (David) Shao
    Chief Financial Officer
    Yisheng Biopharma
  • Dr Maja Sommerfelt at Immune Profiling World Congress
    Dr Maja Sommerfelt
    Chief Scientific Officer
    Bionor Immuno AS
    Dr Vidadi Yusibov at Immune Profiling World Congress
    Dr Vidadi Yusibov
    Executive Director
    Fraunhofer Center for Molecular Biotechnology

 

VIEW 2017 SPEAKERS

Companies Who Attended in 2016

Precision Biologics
MDS
INSERM
Adaptimmune
Merck Research Laboratories
IrsiCaixa A.I.D.S. Research Institute
Tel Aviv Surasky Medical Center
MedImmune
NIAID
Advaxis
Adaptive Biotechnologies
Fraunhofer I.M.E.
Roche
Aduro Biotech 
Max Planck Institute for Infection Biology
Mayo Research Group
Pfizer
NIH
Weizmann Institute of Science
Emory University School of Medicine
University of Gothenburg
GSK
Stanford University
Repertoire Genesis Inc
iTeos Therapeutics

Call us now:
+44 (0)207 827 5945

 

To sponsor, exhibit or speak:
marc.rhys-evans@terrapinn.com

 

To be there:
BOOK NOW

Sign Up For Event Updates